|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9812 USD | -1.41% |
|
-8.30% | -83.97% |
Company Valuation: Actuate Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 155.5 | 142.2 | 23.56 | - | - |
| Change | - | -8.5% | -83.44% | - | - |
| Enterprise Value (EV) | 155.5 | 142.2 | 23.56 | 23.56 | 23.56 |
| Change | - | -8.5% | -83.44% | 0% | 0% |
| P/E | - | - | - | - | - |
| PBR | - | - | - | - | - |
| PEG | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -1.08x | -0.89x | -0.75x |
| EV / FCF | - | -0x | -1.11x | -0.88x | -0.76x |
| FCF Yield | - | -15.6% | -90.1% | -113% | -132% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | - | - | - | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -25.16 | -22.5 | -21.82 | -26.61 | -31.56 |
| Net income | - | - | - | - | - |
| Net Debt | - | - | - | - | - |
| Reference price 2 | 7.9600 | 6.1200 | 0.9812 | 0.9812 | 0.9812 |
| Nbr of stocks (in thousands) | 19,532 | 23,243 | 24,014 | - | - |
| Announcement Date | 13/03/25 | 26/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 23.56M | |
| 20.78x | 7.37x | 14.79x | 1.43% | 70.88B | |
| 32.47x | 9.38x | 45.35x | 0.04% | 62.49B | |
| -73.25x | 14.16x | -68.28x | -.--% | 26.21B | |
| 30.44x | 6.47x | 16.8x | -.--% | 26.34B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.13B | |
| 28.25x | 5.33x | 17.72x | -.--% | 20.72B | |
| 44.51x | 16.33x | 33.12x | 0.34% | 15.36B | |
| 18.03x | 5.37x | 12.55x | -.--% | 14.46B | |
| -15.41x | 3483.86x | -17.81x | -.--% | 14.25B | |
| Average | 7.90x | 394.85x | 5.28x | 0.2% | 27.49B | |
| Weighted average by Cap. | 12.15x | 188.68x | 11.56x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTU Stock
- Valuation Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
